CompanyDrug

Guangdong Taienkang’s CKBA Ointment for Vitiligo Accepted for Review by China’s NMPA

CompanyDrug

Mabwell’s B7-H3 Targeting ADC 7MW3711 Accepted for Review by China’s NMPA

CompanyDrug

CStone Pharmaceuticals’ Partner Servier Secures EU Approvals for IDH1 Inhibitor Tibsovo

CompanyDrug

Innovent Biologics’ Mazdutide Showcases Weight Loss Efficacy in Phase II Study for Chinese Adults

Policy / Regulatory

Beijing Medical Insurance Bureau Announces Key Healthcare Initiatives and BMI Expansion

CompanyDrug

Joincare Pharmaceutical Receives NMPA Approval for Triptorelin Microspheres for Prostate Cancer

CompanyDrug

Zai Lab’s Repotrectinib on Track for Priority Review by China’s CDE for ROS1+ NSCLC

CompanyDrug

Sichuan Kelun Pharmaceutical’s A166 Anti-HER2 ADC NDA Accepted for Review by NMPA

CompanyDeals

Suzhou Porton Biologics and Synbio Technologies Partner to Advance Cell and Gene Therapy in China

CompanyDrug

Mabwell Bioscience’s 9MW3911 Receives NMPA Approval for Clinical Trial in Advanced Tumors

CompanyDrug

Akeso Biopharma Initiates Phase III Study for Ivonescimab in Non-Small Cell Lung Cancer

CompanyDrug

Zai Lab Limited Reports Q1 2023 Financial Results and Product Highlights